Your Doctor Says You’re Fine — But You Feel Terrible

ByRohan Smith

Why Your Doctor Says You're Fine But You Still Feel Terrible

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

Feeling terrible despite “normal” blood tests is a common clinical scenario that may reflect limitations in standard laboratory reference ranges rather than an absence of physiological dysfunction. Conventional panels such as TSH, cholesterol, and basic metabolic markers are designed to screen for overt disease, not optimal function. Subclinical imbalances in thyroid metabolism, cortisol rhythm, gut microbiome composition, methylation pathways, and nutrient status can all contribute to persistent fatigue, brain fog, pain, and mood disturbance without triggering abnormal results.

In this article, we explore common hidden factors that contribute to persistent symptoms and why traditional testing may not tell the full story.

At a Glance

  • Laboratory reference ranges are derived from population averages that include individuals with early or subclinical disease, meaning “normal” results do not necessarily indicate optimal physiological function [1].
  • Thyroid-stimulating hormone (TSH) levels between 1.0 and 2.0 mIU/L may be associated with fewer symptoms, even though laboratories define the upper limit at 4.0-5.0 mIU/L [2-4].
  • Approximately 90% of the body’s serotonin is produced in the gastrointestinal tract, linking gut microbiome health to mood, sleep, and stress tolerance [6-8].
  • Functional testing tools such as DUTCH hormone panels, Organic Acids Testing (OAT), and comprehensive stool analysis can identify dysfunction patterns invisible to standard blood work.
  • Ferritin levels around 30 micrograms per litre, while technically within range, are frequently associated with fatigue, hair loss, and impaired thyroid conversion [18-20].

The Core Problem: “Normal” Does Not Mean Optimal

Laboratory reference ranges are statistically derived from population samples that include both healthy individuals and those with early or subclinical disease, as demonstrated by Katayev et al. in their analysis published in Clinical Chemistry and Laboratory Medicine [1]. Many people feel dismissed after repeated medical visits where test results are reported as normal despite ongoing symptoms. This disconnect is common and typically reflects a limitation of reference ranges rather than imaginary or psychological causes.

Falling within that range simply means overt disease has not been detected — not that physiology is functioning at an optimal level. The Royal Australian College of General Practitioners (RACGP) and the Australasian Association of Clinical Biochemists (AACB) acknowledge that reference intervals have inherent limitations for individual patient assessment.

Example: Thyroid Function

Thyroid-stimulating hormone (TSH) is often used as the sole marker of thyroid health. While many laboratories define normal TSH as up to 4.0-5.0 mIU/L, research by Wartofsky and Dickey published in the Journal of Clinical Endocrinology and Metabolism suggests that symptom-free individuals tend to cluster between approximately 1.0-2.0 mIU/L [2-4].

TSH Level (mIU/L) Standard Lab Interpretation Functional Medicine Perspective
0.5 – 2.0 Normal May be associated with optimal thyroid function
2.0 – 4.0 Normal May warrant further investigation if symptoms present
4.0 – 5.0 Normal (upper range) Often associated with subclinical hypothyroid patterns
> 5.0 Elevated / Hypothyroid Typically flagged for treatment

A TSH of 3.5 mIU/L may therefore be labelled “normal” yet still be associated with fatigue, cold intolerance, weight gain, or cognitive slowing — a pattern often referred to as subclinical thyroid dysfunction. Peeters, writing in the New England Journal of Medicine, highlighted that subclinical hypothyroidism remains a significant clinical consideration [5].

What Standard Testing Commonly Misses

Typical GP blood panels assess around 10-15 markers and are primarily designed to screen for organ failure or advanced disease rather than functional efficiency, according to pathology guidelines from the National Association of Testing Authorities (NATA).

Physiological System Common Symptoms Standard Panel Coverage
Gastrointestinal and microbiome health Bloating, IBS-type symptoms, food sensitivities Not assessed
Stress-hormone rhythm (HPA axis) Fatigue, insomnia, anxiety, burnout Single cortisol only (if ordered)
Nutrient-dependent metabolic pathways Low energy, poor recovery, cognitive decline Limited (iron, B12 occasionally)
Neuroimmune and inflammatory regulation Chronic pain, brain fog, mood instability CRP only (if ordered)

Gut Health

The gut microbiome plays a central role in immune regulation, nutrient absorption, and neurotransmitter signalling. Research by Yano et al. published in Cell demonstrated that approximately 90% of serotonin is produced in the gastrointestinal tract by enterochromaffin cells, influencing mood, sleep, and stress tolerance [6-8]. Cryan and Dinan’s landmark review in Nature Reviews Neuroscience further established the gut-brain axis as a key regulator of behaviour and cognition [7]. Gut microbiome imbalance and intestinal inflammation are not detected through routine blood testing.

Cortisol Rhythm

Cortisol is a glucocorticoid hormone regulated by the hypothalamic-pituitary-adrenal (HPA) axis with a diurnal rhythm, normally peaking in the morning and gradually declining toward night. Adam et al., publishing in Psychoneuroendocrinology, found that disruption of this cortisol awakening response has been associated with fatigue, sleep disturbance, mood changes, and reduced stress resilience [9,10]. Single serum cortisol measurements do not capture this dynamic pattern.

Methylation Pathways

Methylation refers to a group of biochemical reactions dependent on folate, vitamin B12, and vitamin B6, involved in detoxification, neurotransmitter metabolism, DNA regulation, and hormone clearance. Stover’s research in the American Journal of Clinical Nutrition highlighted that variants in the MTHFR gene (methylenetetrahydrofolate reductase) can affect homocysteine metabolism and one-carbon metabolism efficiency [11,12]. Methylation pathways may function inefficiently in some individuals, contributing to fatigue, poor stress tolerance, and hormonal symptoms, yet they are not directly assessed in standard pathology testing.

The Functional Medicine Difference

Functional medicine testing, as practised by the Institute for Functional Medicine (IFM), aims to assess how well systems are functioning rather than simply determining whether disease is present.

Functional Test What It Assesses Key Markers Identified
DUTCH Complete (Precision Analytical) Hormone metabolites and cortisol rhythm via dried urine Oestrogen metabolites, cortisol awakening response, melatonin, DHEA-S [13]
Organic Acids Test (Mosaic Diagnostics) Functional nutrient status, mitochondrial function, microbial metabolites Krebs cycle intermediates, neurotransmitter metabolites (HVA, VMA), oxalates [14-16]
Comprehensive stool and microbiome analysis Digestion, inflammation, microbial balance, immune signalling Calprotectin, secretory IgA, short-chain fatty acids, commensal diversity [17]

These tools are not used in isolation to diagnose disease, but to identify patterns of dysfunction that may help explain persistent or unexplained symptoms.

Interpreting Existing Blood Tests Differently

Valuable clinical information often already exists within previous GP-ordered tests — it may simply not have been interpreted through an optimal-range or systems-based lens.

Marker Standard Interpretation Functional Perspective
Ferritin ~30 micrograms/L Normal (above lower reference limit) Frequently associated with fatigue, hair loss, and impaired thyroid function. Camaschella’s review in NEJM highlights the clinical significance of iron depletion before anaemia develops [18-20]
Mildly elevated ALT/GGT Normal or borderline May reflect oxidative stress, non-alcoholic fatty liver disease (NAFLD), or metabolic burden rather than overt liver disease [21]
Elevated LDL cholesterol Cardiovascular risk marker Can provide insight into inflammation, insulin resistance, or thyroid status (Duntas, Thyroid), not just cardiovascular risk [22]

For this reason, reviewing prior pathology is often the most efficient starting point before deciding whether additional investigations are warranted.

Next Steps

  1. Gather your existing results: Collect recent blood work and pathology reports so they can be reviewed through an optimal-range lens rather than just a disease-screening perspective.
  2. Identify your symptom pattern: Note which symptoms persist — fatigue, brain fog, digestive issues, mood changes — and when they are worst, to help guide which systems to investigate first.
  3. Consider functional testing: If standard results appear “normal” but symptoms continue, targeted assessments such as DUTCH hormone testing, Organic Acids Testing, or comprehensive gut analysis may reveal underlying contributors.

Frequently Asked Questions

If my blood tests are normal, could my symptoms still be physiological?
Yes. Standard blood tests are designed to detect overt disease rather than early, functional, or system-level dysfunction. Many physiological imbalances — including disrupted stress-hormone signalling, gut-immune interactions, nutrient insufficiencies, and inflammatory load — can affect how you feel without pushing markers outside laboratory reference ranges.

Does this mean my symptoms are “all in my head”?
No. Persistent symptoms with normal test results are rarely psychological in origin alone. Research shows that subclinical metabolic, immune, and neuroendocrine patterns can produce real, measurable symptoms even when conventional pathology appears unremarkable. The issue is often incomplete testing or interpretation, not imagined illness.

Should I repeat standard blood tests or look at them differently?
In many cases, reviewing existing blood work through an optimal-range and systems-based lens is more informative than repeating the same tests. Markers such as ferritin, thyroid indices, liver enzymes, and lipid patterns can provide valuable insight when interpreted in context with symptoms, lifestyle, and stress physiology.

Key Insights

  • “Normal” lab results reflect population-based reference ranges, not individual optimal function — falling within range does not guarantee you feel well
  • Standard GP panels screen for advanced disease but often miss gut dysfunction, cortisol rhythm disruption, methylation inefficiency, and nutrient-dependent metabolic issues
  • Functional testing tools like DUTCH, OAT, and microbiome analysis can identify patterns of dysfunction that explain persistent symptoms
  • Existing blood work often contains valuable clues when reinterpreted through an optimal-range, systems-based lens
  • Persistent symptoms are not a personal failing — they typically reflect measurable physiological patterns that standard testing was not designed to detect

Citable Takeaways

  1. Laboratory reference ranges include individuals with early disease in their sample populations, meaning “normal” results may not reflect optimal physiological function (Katayev et al., Clin Chim Acta, 2010).
  2. Symptom-free individuals tend to have TSH levels between approximately 1.0 and 2.0 mIU/L, substantially lower than the standard upper reference limit of 4.0-5.0 mIU/L (Wartofsky and Dickey, J Clin Endocrinol Metab, 2005).
  3. Approximately 90% of the body’s serotonin is synthesised in the gastrointestinal tract by indigenous gut bacteria, linking microbiome composition to mood and neurological function (Yano et al., Cell, 2015).
  4. Disrupted diurnal cortisol slopes are associated with adverse mental and physical health outcomes, yet single serum cortisol measurements cannot capture this pattern (Adam et al., Psychoneuroendocrinology, 2017).
  5. Ferritin levels around 30 micrograms per litre, while within standard reference ranges, are frequently associated with fatigue, hair loss, and impaired thyroid hormone conversion (Camaschella, N Engl J Med, 2015; Beard, J Nutr, 2001).

Uncover What Standard Tests Miss

If you have been told your results are “normal” but continue to feel unwell, there may be underlying contributors that standard pathology was not designed to detect. At Elemental Health and Nutrition, we review existing results through an optimal-range lens and use targeted functional testing to identify the physiological patterns behind persistent symptoms.

Book an Appointment

References

  1. Katayev A, et al. Clin Chim Acta. 2010.
  2. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005 Sep;90(9):5483-8. https://doi.org/10.1210/jc.2005-0455
  3. Andersen S, et al. Narrow individual variations in serum T(4) and T(3) in normal subjects. J Clin Endocrinol Metab. 2002 Mar;87(3):1068-72. https://doi.org/10.1210/jc.87.3.1068
  4. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008 Feb;29(1):76-131. https://doi.org/10.1210/er.2006-0043
  5. Peeters RP. Subclinical Hypothyroidism. N Engl J Med. 2017 Apr 27;376(17):e36. https://doi.org/10.1056/NEJMcp1611144
  6. Gershon MD. The enteric nervous system: a second brain. Hosp Pract. 1999 Jul 15;34(7):31-2, 35-8, 41-2 passim.
  7. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012 Oct;13(10):701-12. https://doi.org/10.1038/nrn3346
  8. Yano JM, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015 Apr 9;161(2):264-76. https://doi.org/10.1016/j.cell.2015.02.047
  9. Adam EK, et al. Diurnal cortisol slopes and mental and physical health outcomes. Psychoneuroendocrinology. 2017 Sep;83:25-41. https://doi.org/10.1016/j.psyneuen.2017.05.018
  10. Fries E, et al. A new view on hypocortisolism. Psychoneuroendocrinology. 2005 Oct;30(9):1010-6.
  11. Stover PJ. One-carbon metabolism in health and disease. Am J Clin Nutr. 2009 Mar;89(3):1033S-1038S.
  12. Crider KS, et al. Prenatal folic acid supplementation and risk of congenital heart defects. Am J Clin Nutr. 2012 Jul;96(1):114-22.
  13. Newman MS, et al. Steroid hormone analysis by tandem mass spectrometry in clinical laboratories. J Steroid Biochem Mol Biol. 2020 Jan;196:105501.
  14. Lord RS, et al. Organic acids: a new tool for functional assessment. Altern Med Rev. 2008 Sep;13(3):216-28.
  15. Lambrecht NJ, et al. Biochemical markers of bone turnover. Clin Biochem. 2012;45(13-14):1063-71.
  16. Sweetman L. Organic acid analysis. J Inherit Metab Dis. 2013;36(3):513-20.
  17. Vipperla K, O’Keefe SJ. The microbiota and its metabolites in colonic diseases. Clin Gastroenterol Hepatol. 2016;14(12):1686-92.
  18. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015 Feb 19;372(8):783-92. https://doi.org/10.1056/NEJMra1401038
  19. Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr. 2001 Feb;131(2S-2):568S-579S. https://doi.org/10.1093/jn/131.2.568S
  20. Zimmermann MB, et al. Iodine deficiency disorders. Thyroid. 2008;18(12):1269-77.
  21. Sanyal AJ. Nonalcoholic fatty liver disease. Hepatology. 2011;54(5):1845-55.
  22. Duntas LH. Thyroid function in obesity. Thyroid. 2002;12(10):879-83.

Ready to find answers?

Stop surviving. Start recovering.

Similar Posts